Largest disclosed lower bound
Tom Malinowski · $15.0K–$50.0K
Purchase · traded 2019-05-31 → filed 2021-08-26. Ranked over every PCRX row by the provable lower bound, never a point estimate.
Public record / Tickers / PCRX
PCRX — Pacira BioSciences, Inc.†
Both disclosure regimes on one name: who in Congress filed about PCRX, which institutions reported holding it. Each section keeps its own clock — congressional trades on the 45-day PTR clock, 13F holdings as quarter-end snapshots.
- Congress txns
- 10 all PTR rows naming PCRX
- Members · 12m
- 0 0 buys · 0 sells · by trade date
- Latest PTR
- 08-26 filed 2021-08-26
- 13F holders
- 226 top-226 slice · 2026-03-31
Congress = transactions in statutory ranges, 45-day lag · Institutions = quarter-end positions, 45-day lagas of 2026-09-14 13:21 UTCno price data — a disclosure record, not a chart
Congress · trailing 12 months
No member disclosed PCRX in the trailing 12 months
Counts of disclosures by trade date, not dollars — ranges cannot be netted across members. Flow ranges per member are in the table below.
Late filings
10 rows filed past the 45-day window
Late disclosure is stated on the row, never editorialised. Both dates and the receipt stay on every row.
Congress · disclosure timeline
TRADE DATES · 24M · ▲ BUY ▼ SELL · HEIGHT = LOG LOWER BOUNDNo dated PCRX rows fall inside the trailing 24 months by trade date.
Trade date, not filing date — the lag lives in the table below. 0 rows placed.
PLANNED institutional holder flow by quarter
Congressional disclosures
ALL PTR ROWS NAMING PCRX · SORTED FILED ↓ · STATUTORY RANGES · FILED ≤45D LATEfull congressional view ↗| Filed ▾ | Member | Side · Owner | Traded · Lag | Amount | Range · Flags | Src |
|---|---|---|---|---|---|---|
| 2021-08-26 | Tom Malinowski D–NJ-7 | Purchase | Traded 01-25 LATE·213d | $1K–$15K | ||
| 2021-08-26 | Tom Malinowski D–NJ-7 | Purchase | Traded 2019-05-31 LATE·818d | $15K–$50K | ||
| 2021-06-23 | Tom Malinowski D–NJ-7 | Purchase | Traded 05-06 LATE·48d | $1K–$15K | ||
| 2021-06-12 | Tom Malinowski D–NJ-7 | Purchase | Traded 04-20 LATE·53d | $1K–$15K | ||
| 2021-03-05 | Tom Malinowski D–NJ-7 | Purchase | Traded 01-15 LATE·49d | $1K–$15K |
Traded → filed dates on every rowEach row shows the trade date and the filing date; the gap between them is the disclosure lag.all 10 ↗
Members active in PCRX
12M · NET LOWER BOUND · COMMITTEES AS OF TRADE DATE · SNAPSHOT 2026-09-14No member disclosed PCRX in the trailing 12 months.
Congress ↔ notable managers · PCRX
who in Congress disclosed purchases or sales beside which notable managers added or trimmedCongress · last 90 days
- Buyers
- 0 — —
- Sellers
- 0 — —
filed 2026-06-16 → 2026-09-14 · totals are statutory ranges
Notable managers · quarter ended 2026-03-31
- Adding
- 1 Gotham Asset Management $1.0M held
- Trimming
- 1 Caxton Associates $798K held
new + add vs trim + exit, by shares · $ = reported value now, not the change · PACIRA BIOSCIENCES INC
| Date | Who | Change | Size |
|---|---|---|---|
| 2026-05-15 | Gotham Asset Management 13F | add | +12,011 sh |
| 2026-05-14 | Caxton Associates 13F | trim | −14,683 sh |
2 newest rows · Congress rows date by filing, 13F rows by quarter end · a 13F row is a quarter-end snapshot, not a trade
Institutional holders · 13F · Quarter ended 2026-03-31 · longs only
The published aggregate ranks the top 226 holders per issuer — a build parameter of the Public Filings aggregation, not a census. Rows beyond it exist in individual filings on EDGAR. methodology §13F ↗
§ derived by Public Filings from the published aggregate (agg_issuer_top_holders); per-filer filed dates, share counts and document links are not in the published aggregate — the EDGAR link opens the filer's 13F list
n/c Newest filing in this build: 2026-07-31. Per-row filing dates are on each receipt.
Crowding — not available in this build. No holder rows for the selected period, so no percentile can be ranked.
Do the two regimes agree?
TRAILING 12M · CONGRESS vs FILERS NETCongress net (rows)no rows
Congress net ($ bound)$0
Filers net (actions)not in build
Filers net ($ Q/Q)not in build
The filer side needs per-issuer quarter-over-quarter actions, which the published aggregate does not carry for this issuer. Convergence and divergence are stated only when both sides are computed.
Signals on PCRX
RETAINED WINDOW · ACTIVE HITSZero hits on PCRX in the retained window — a computed answer over every rule, not missing coverage.
Planned modules for PCRX · financials and macro
Financials — as filed PLANNED
PCRX's as-reported XBRL fundamentals will appear here when the financials module passes its gates. Until then: PCRX on EDGAR ↗
Macro context PLANNED
Rates, inflation, and positioning series land here with the macro module — vintage-aware, never nowcast.
† issuer name from the SEC's present-day ticker file (company_tickers.json) — a present-day mapping, not the name as of each filing